id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-263285-89zqgqx1	Sethi, Sanjum S.	Right Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team	2020-05-29		.txt	text/plain	1855	117	45	After presenting a case of right ventricular thrombus in a COVID-19 patient, we discuss the unique challenges in the workup and treatment of COVID-19 patients highlighting our COVID-19 modified pulmonary embolism response team (PERT) algorithm. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19related critical illness and multiorgan dysfunction in a subset of those infected. Given these findings, the pulmonary embolism response team (PERT) was consulted and the patient was given 100 mg (over 2 hours) of tissue-type plasminogen activator (tPA) and systemic anticoagulation with unfractionated heparin once the tPA infusion was complete. The usual risk stratification schema for acute pulmonary embolism rely on a combination of hemodynamic clinical parameters, such as hypoxemia, tachycardia, and hypotension along with serum biomarkers, such as troponin or brain natriuretic peptide followed by confirmatory imaging tests.	./cache/cord-263285-89zqgqx1.txt	./txt/cord-263285-89zqgqx1.txt